Athanor Capital, LP Igm Biosciences, Inc. Transaction History

Athanor Capital, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$57.98 - $96.6 $187,507 - $312,404	-3,234 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$71.56 - $121.23 $499,417 - $846,064	-6,979 Reduced 68.33%	3,234 $248,000
Q4 2020 Feb 16, 2021	BUY	$47.41 - $115.03 $280,287 - $680,057	5,912 Added 137.46%	10,213 $902,000
Q3 2020 Nov 16, 2020	SELL	$43.0 - $84.01 $134,504 - $262,783	-3,128 Reduced 42.11%	4,301 $317,000
Q2 2020 Aug 13, 2020	BUY	$51.3 - $75.21 $381,107 - $558,735	7,429 New	7,429 $542,000

21.4M

39.5K

16.5K

Ticker IGMS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,969,000
Market Cap $500M
Description
IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...

Get notified when there are updates to the investment portfolio of Athanor Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Athanor Capital, LP with notifications on news.